Walleye Capital’s Envoy Medical Warrant COCHW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-32,661
Closed -$1.52K 4364
2024
Q4
$1.52K Sell
32,661
-699,377
-96% -$43.2K ﹤0.01% 4679
2024
Q3
$58.6K Hold
732,038
﹤0.01% 4594
2024
Q2
$36.6K Buy
732,038
+150,528
+26% +$16.5K ﹤0.01% 5011
2024
Q1
$61.9K Buy
581,510
+228,522
+65% +$15.3K ﹤0.01% 4607
2023
Q4
$7.06K Buy
+352,988
New +$9.53K ﹤0.01% 4609
2023
Q3
Sell
-44,455
Closed -$2.22K 4942
2023
Q2
$2.22K Hold
44,455
﹤0.01% 4144
2023
Q1
$1.67K Buy
44,455
+17,030
+62% +$957 ﹤0.01% 3801
2022
Q4
$1.04K Hold
27,425
﹤0.01% 3052
2022
Q3
$2K Hold
27,425
﹤0.01% 3056
2022
Q2
$3K Hold
27,425
﹤0.01% 2199
2022
Q1
$7K Buy
27,425
+9,159
+50% +$3.94K ﹤0.01% 2152
2021
Q4
$14K Buy
+18,266
New +$13.4K ﹤0.01% 1988

Other funds holding COCHW

Walleye Capital's COCHW Position: Q1 2025 in Review

Walleye Capital sold out of Envoy Medical Warrant (COCHW) in Q1 2025, closing a stake of 32,661 shares — an estimated $1.52K sold.

Walleye Capital first reported a position in COCHW in Q4 2021 and held it in 12 quarters. The position peaked at $61.9K in Q1 2024. 36 funds tracked by Wall St. Rank hold COCHW as of Q1 2025.

  • Walleye Capital reported no remaining Envoy Medical Warrant position as of Q1 2025 after selling out during the quarter.
  • Walleye Capital sold 32,661 Envoy Medical Warrant shares in Q1 2025, an estimated $1.52K.
  • Walleye Capital first reported a position in Envoy Medical Warrant in Q4 2021 and held it in 12 quarters.
  • Walleye Capital's Envoy Medical Warrant position peaked at $61.9K in Q1 2024.
  • 36 funds tracked by Wall St. Rank held Envoy Medical Warrant as of Q1 2025.

Based on Walleye Capital's 13F filing for Q1 2025, filed 14 May 2025.